Dr. Passeri is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit St
Yaw 5a
Boston, MA 02114Phone+1 617-726-2066Fax+1 617-643-3963
Education & Training
- Massachusetts General HospitalFellowship, Cardiovascular Disease, 2003 - 2007
- Massachusetts General HospitalResidency, Internal Medicine, 2000 - 2003
- New York Medical CollegeClass of 2000
Certifications & Licensure
- MA State Medical License 2003 - 2025
- American Board of Internal Medicine Cardiovascular Disease
- National Board of Echocardiography
Clinical Trials
- 2019-06 TRISCEND Study Start of enrollment: 2020 May 06
Publications & Presentations
PubMed
- 453 citationsEarly detection and prediction of cardiotoxicity in chemotherapy-treated patients.Heloisa Sawaya, Igal A. Sebag, Juan Carlos Plana, James L. Januzzi, Bonnie Ky
The American Journal of Cardiology. 2011-05-01 - 20 citationsThe aortic valve calcium nodule score (AVCNS) independently predicts paravalvular regurgitation after transcatheter aortic valve replacement (TAVR)Lorenzo Azzalini, Brian B. Ghoshhajra, Sammy Elmariah, Jonathan J. Passeri, Ignacio Inglessis
Journal of Cardiovascular Computed Tomography. 2014-03-01 - 368 citationsEarly increases in multiple biomarkers predict subsequent cardiotoxicity in patients with breast cancer treated with doxorubicin, taxanes, and trastuzumab.Bonnie Ky, Mary E. Putt, Heloisa Sawaya, Benjamin French, James L. Januzzi
Journal of the American College of Cardiology. 2014-03-04
Press Mentions
- ‘I Know a Lot of People Who Have Quit’: Friday Deadline for Boston Hospital Employees to Get COVID VaccineOctober 15th, 2021
- Massachusetts General Hospital First in New England to Perform New Procedures for Tricuspid Valve DiseaseAugust 25th, 2020
- ACC/AATS/AHA/ASE/EACTS/HVS/SCA/SCAI/SCCT/SCMR/STS 2017 Appropriate Use Criteria for the Treatment of Patients with Severe Aortic StenosisJuly 16th, 2020
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: